首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Application of machine learning classification for structural brain MRI in mood disorders: Critical review from a clinical perspective
【24h】

Application of machine learning classification for structural brain MRI in mood disorders: Critical review from a clinical perspective

机译:机器学习分类在情绪障碍中的结构脑MRI应用:临床视角的关键综述

获取原文
获取原文并翻译 | 示例
           

摘要

Mood disorders are a highly prevalent group of mental disorders causing substantial socioeconomic burden. There are various methodological approaches for identifying the underlying mechanisms of the etiology, symptomatology, and therapeutics of mood disorders; however, neuroimaging studies have provided the most direct evidence for mood disorder neural substrates by visualizing the brains of living individuals. The prefrontal cortex, hippocampus, amygdala, thalamus, ventral striatum, and corpus callosum are associated with depression and bipolar disorder. Identifying the distinct and common contributions of these anatomical regions to depression and bipolar disorder have broadened and deepened our understanding of mood disorders. However, the extent to which neuroimaging research findings contribute to clinical practice in the real-world setting is unclear. As traditional or non-machine learning MRI studies have analyzed group-level differences, it is not possible to directly translate findings from research to clinical practice; the knowledge gained pertains to the disorder, but not to individuals. On the other hand, a machine learning approach makes it possible to provide individual-level classifications. For the past two decades, many studies have reported on the classification accuracy of machine learning-based neuroimaging studies from the perspective of diagnosis and treatment response. However, for the application of a machine learning-based brain MRI approach in real world clinical settings, several major issues should be considered. Secondary changes due to illness duration and medication, clinical subtypes and heterogeneity, comorbidities, and cost-effectiveness restrict the generalization of the current machine learning findings. Sophisticated classification of clinical and diagnostic subtypes is needed. Additionally, as the approach is inevitably limited by sample size, multi-site participation and data-sharing are needed in the future.
机译:情绪障碍是一种高度普遍的精神障碍群,导致了大量的社会经济负担。有各种方法论方法,用于鉴定情绪障碍的病因,症状和治疗症的潜在机制;然而,神经影像学研究通过可视化活性的脑质,为情绪障碍神经基质提供了最直接的证据。前额外的皮质,海马,杏仁盐,丘脑,腹侧纹状体和语料库胼um与抑郁和双相障碍有关。确定这些解剖区域对抑郁和双相情感障碍的不同和共同贡献扩大并深化了我们对情绪障碍的理解。然而,神经影像研究结果在实际环境中有助于临床实践的程度尚不清楚。由于传统或非机器学习MRI研究分析了组级差异,因此无法将研究结果直接转化为临床实践;获得的知识涉及疾病,但不是个人。另一方面,机器学习方法使得可以提供单独的分类。在过去的二十年中,许多研究报告了从诊断和治疗反应的角度来看的基于机器学习的神经影像学研究的分类准确性。但是,对于在现实世界临床环境中应用基于机器学习的脑MRI方法,应考虑几个主要问题。由于疾病的持续时间和药物,临床亚型和异质性,合并症和成本效益导致的二次变化限制了当前机器学习结果的泛化。需要复杂的临床和诊断亚型分类。此外,由于该方法不可避免地受到样本大小的限制,因此将来需要多站点参与和数据共享。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号